Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.545 AUD | +4.81% | +12.37% | -18.05% |
04-19 | INOVIQ Concludes Analytical Validation for Ovarian Cancer Blood Test | MT |
04-15 | Fears of Middle East Conflict Escalation Quell Appetite for Australian Shares | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.05% | 31.61M | |
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+43.62% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |
- Stock Market
- Equities
- IIQ Stock
- News INOVIQ Ltd
- Inoviq Advances Commercial Sales of Medical Products in the US; Moves Research Facility to Australia